Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism-Reference-Cited by-同舟云学术

Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism

Published:2017-02-18 Issue:3 Volume:15 Page:429-438
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Trujillo-Santos J.¹,Bergmann J. F.²,Bortoluzzi C.³,López-Reyes R.⁴,Giorgi-Pierfranceschi M.⁵,López-Sáez J. B.⁶,Ferrazzi P.⁷,Bascuñana J.⁸,Suriñach J. M.⁹,Monreal M.¹⁰

Affiliation:

1. Department of Internal Medicine; Hospital General Universitario Santa Lucía; Murcia Spain

2. Department of Internal Medicine; Hôpital Lariboisiere; Paris France

3. Department of Internal Medicine; Ospedale SS. Giovanni e Paolo di Venezia; Venice Italy

4. Department of Pneumonology; Hospital Universitari i Politècnic La Fe; Valencia Spain

5. Emergency Department; Hospital of Val d'Arda; Piacenza Italy

6. Department of Internal Medicine; Hospital Universitario de Puerto Real; Cádiz Spain

7. Centro Trombosi; Istituto Clinico Humanitas IRCCS; Milan Italy

8. Department of Internal Medicine; Hospital Infanta Leonor; Madrid Spain

9. Department of Internal Medicine; Hospital Vall d′Hebrón; Barcelona Spain

10. Department of Internal Medicine; Hospital Universitari Germans Trias i Pujol de Badalona; Universidad Católica de Murcia; Murcia Spain

Funder

Sanofi

Bayer Pharma AG

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13616/fullpdf

Reference26 articles.

1. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Kearon;Chest,2012

2. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry;Ruíz-Giménez;Thromb Haemost,2008

3. Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE Registry;Nieto;J Thromb Haemost,2010

4. Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis;Sánchez Muñoz-Torrero;J Vasc Surg,2011

5. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk;Muriel;J Am Coll Cardiol,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enoxaparin for Long-Term Therapy of Venous Thromboembolism in Patients with Cancer and Renal Insufficiency;Thrombosis and Haemostasis;2023-10-13

2. Once-daily Compared With Twice-daily Enoxaparin Maintenance Therapy Appears Safe and Efficacious in Pediatric Venous Thromboembolism;Journal of Pediatric Hematology/Oncology;2022-11-28

3. Critical appraisal of evidence for anti-Xa monitoring and dosing of low-molecular-weight heparin in renal insufficiency;Expert Review of Clinical Pharmacology;2022-10-03

4. Tinzaparin—a review of its molecular profile, pharmacology, special properties, and clinical uses;European Journal of Clinical Pharmacology;2022-07-23

5. Herz-Kreislauf-System;Arzneimitteltherapie in der Palliativmedizin;2022